Axsome Therapeutics Inc (AXSM)
77.03
+1.09
(+1.44%)
USD |
NASDAQ |
May 07, 16:00
77.03
0.00 (0.00%)
After-Hours: 18:42
Axsome Therapeutics Shares Outstanding: 47.37M for Feb. 13, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 13, 2024 | 47.37M |
December 31, 2023 | 47.35M |
October 31, 2023 | 47.32M |
September 30, 2023 | 47.32M |
July 31, 2023 | 47.19M |
July 01, 2023 | 47.02M |
June 30, 2023 | 46.57M |
May 01, 2023 | 43.57M |
April 10, 2023 | 43.55M |
March 31, 2023 | 43.55M |
February 21, 2023 | 43.52M |
December 31, 2022 | 43.50M |
October 31, 2022 | 43.43M |
September 30, 2022 | 43.43M |
August 19, 2022 | 42.88M |
August 01, 2022 | 40.30M |
June 30, 2022 | 39.91M |
April 26, 2022 | 38.91M |
April 11, 2022 | 38.91M |
March 31, 2022 | 38.88M |
February 22, 2022 | 38.48M |
December 31, 2021 | 37.82M |
November 01, 2021 | 37.69M |
September 30, 2021 | 37.69M |
August 02, 2021 | 37.68M |
Date | Value |
---|---|
June 30, 2021 | 37.65M |
May 03, 2021 | 37.57M |
April 12, 2021 | 37.56M |
March 31, 2021 | 37.56M |
February 22, 2021 | 37.41M |
December 31, 2020 | 37.37M |
October 30, 2020 | 37.34M |
September 30, 2020 | 37.34M |
August 03, 2020 | 37.28M |
June 30, 2020 | 37.27M |
May 01, 2020 | 37.08M |
April 09, 2020 | 37.08M |
March 31, 2020 | 37.08M |
March 06, 2020 | 37.08M |
January 10, 2020 | 37.02M |
January 09, 2020 | 36.93M |
December 31, 2019 | 36.93M |
December 23, 2019 | 36.81M |
November 01, 2019 | 34.51M |
September 30, 2019 | 34.50M |
August 02, 2019 | 34.42M |
June 30, 2019 | 34.33M |
May 03, 2019 | 33.31M |
April 22, 2019 | 33.31M |
March 31, 2019 | 33.30M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
34.33M
Minimum
Jun 30 2019
47.37M
Maximum
Feb 13 2024
39.83M
Average
37.69M
Median
Sep 30 2021
Shares Outstanding Benchmarks
Krystal Biotech Inc | 28.51M |
Amgen Inc | 536.43M |
Vertex Pharmaceuticals Inc | 258.31M |
Alnylam Pharmaceuticals Inc | 126.49M |
Catalyst Pharmaceuticals Inc | 117.86M |